Aurelie Fabre
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
O'Dowd E, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M, Brunelli A, Chorostowska-Wynimko J, Decaluwe H, Deruysscher D, De Wever W, Donoghue M, Fabre A, Gaga M, van Geffen W, Hardavella G, Kauczor H, Kerpel-Fronius A, van Meerbeeck J, Nagavci B, Nestle U, Novoa N, Prosch H, Prokop M, Putora P, Rawlinson J, Revel M, Snoeckx A, Veronesi G, Vliegenthart R, Weckbach S, Blum T, Baldwin D. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. Eur Respir J 2023; 62
19.10.2023ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
19.10.2023Eur Respir J 2023; 62
O'Dowd Emma L, Tietzova Ilona, Bartlett Emily, Devaraj Anand, Biederer Jürgen, Brambilla Marco, Brunelli Alessandro, Chorostowska-Wynimko Joanna, Decaluwe Herbert, Deruysscher Dirk, De Wever Walter, Donoghue Matthew, Fabre Aurelie, Gaga Mina, van Geffen Wouter, Hardavella Georgia, Kauczor Hans-Ulrich, Kerpel-Fronius Anna, van Meerbeeck Jan P, Nagavci Blin, Nestle Ursula, Novoa Nuria, Prosch Helmut, Prokop Mathias, Putora Paul Martin, Rawlinson Janette, Revel Marie-Pierre, Snoeckx Annemiek, Veronesi Giulia, Vliegenthart Rozemarijn, Weckbach Sabine, Blum Torsten G, Baldwin David
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
O'Dowd E, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M, Brunelli A, Chorostowska-Wynimko J, Decaluwe H, Deruysscher D, De Wever W, Donoghue M, Fabre A, Gaga M, van Geffen W, Hardavella G, Kauczor H, Kerpel-Fronius A, van Meerbeeck J, Nagavci B, Nestle U, Novoa N, Prosch H, Prokop M, Putora P, Rawlinson J, Revel M, Snoeckx A, Veronesi G, Vliegenthart R, Weckbach S, Blum T, Baldwin D. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. Eur J Cardiothorac Surg 2023; 64
04.10.2023ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
04.10.2023Eur J Cardiothorac Surg 2023; 64
O'Dowd Emma L, Tietzova Ilona, Bartlett Emily, Devaraj Anand, Biederer Jürgen, Brambilla Marco, Brunelli Alessandro, Chorostowska-Wynimko Joanna, Decaluwe Herbert, Deruysscher Dirk, De Wever Walter, Donoghue Matthew, Fabre Aurelie, Gaga Mina, van Geffen Wouter, Hardavella Georgia, Kauczor Hans-Ulrich, Kerpel-Fronius Anna, van Meerbeeck Jan P, Nagavci Blin, Nestle Ursula, Novoa Nuria, Prosch Helmut, Prokop Mathias, Putora Paul Martin, Rawlinson Janette, Revel Marie-Pierre, Snoeckx Annemiek, Veronesi Giulia, Vliegenthart Rozemarijn, Weckbach Sabine, Blum Torsten G, Baldwin David
Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples
O'Brien O, Gray S, Jörger M, Jochum W, Fabre A, Cuffe S, Nicholson S, Leonard N, Geoghegan O, O'Brien C, Wright M, Finn S. Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples. Diagnostics (Basel) 2019; 9
18.01.2019Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples
18.01.2019Diagnostics (Basel) 2019; 9
O'Brien Odharnaith, Gray Steven G, Jörger Markus, Jochum Wolfram, Fabre Aurelie, Cuffe Sinead, Nicholson Siobhan, Leonard Niamh, Geoghegan Orla, O'Brien Cathal, Wright Mark C, Finn Stephen P